Biotechnology

enVVeno Medical Reports Third Quarter 2026 Financial Results and Prepares to Treat First Patients in FDA-Approved TAVVE Pivotal Study

October 30, 2026 8:30 AM

enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today reported financial results for the third quarter ended September 30, 2026. Cash and investments at the end of the quarter were $18.5 million, with a quarterly burn of approximately $3 million. The Company is on track to begin Part 1 of the TAVVE® U.S. pivotal study for its enVVe® system, a first-in-class, non-surgical replacement venous valve, in the fourth...

Read more

Change in Number of Shares and Votes in Alligator Bioscience AB

October 30, 2026 4:20 AM

Alligator Bioscience (STO:ATORX) - During October 2026, the number of shares and votes in Alligator Bioscience AB ("Alligator Bioscience") has increased as a result of the rights issue of units which was resolved by the Board of Directors on 23 July 2026 and approved by the extraordinary general meeting on 26 August 2026. As of 30 October 2026, the total number of outstanding shares and votes in Alligator Bioscience amounts to 3,568,106,848,...

Read more

TeselaGen and Tecnológico de Monterrey Announce Collaboration to Advance AI-Driven Scientific Research

October 29, 2026 10:45 AM

TeselaGen, a leading provider of AI-enabled software for the design and execution of biological research, today announced a multi-year collaboration agreement with Tecnológico de Monterrey (TEC), one of Latin America's most prestigious and innovative research institutions. The collaboration aims to accelerate scientific discovery through the use of advanced biological design tools and artificial intelligence, empowering researchers at TEC to...

Read more

Synexis and Nieser Expand Continuous Pathogen Control Across a Region of South America's Poultry Industry

October 29, 2026 9:55 AM

Synexis®, LLC, the leader in touchless, continuous pathogen control technology, announced a strategic collaboration with Nieser, a family-owned biosecurity company with more than 30 years of experience supporting intensive animal production. This collaboration will expand access to Synexis patented DHP® technology in Argentina, Uruguay and Paraguay, giving poultry producers an added layer of biosecurity to continuously address microbial...

Read more

AminoShift Research LLC Launches Research-Materials Platform with Per-Lot Documentation and Public Batch Verification

October 29, 2026 8:30 AM

AminoShift Research LLC ("AminoShift"), a Texas supplier of research materials for laboratories and qualified researchers, today announced the launch of its platform at aminoshift.com. The platform organizes materials by research area and attaches a documentation record to each lot, which anyone can look up through a public batch-verification tool before placing an order. "Researchers are usually asked to trust a label," said Lyth Elkour,...

Read more

Bio Essence Unveils Practitioner-Controlled Knowledge Vault, Tackling AI's Trust Barrier in Healthcare

October 29, 2026 8:00 AM

Bio Essence Corporation (OTCQB:BIOE) ("Bio Essence" or the "Company") today announced the completion of a Practitioner Knowledge Vault prototype that lets healthcare practitioners keep control of their professional knowledge instead of surrendering it as generic AI training data. The milestone, which includes full architecture and security/data-flow design, is the first major step in the Company's MediFlow Practitioner AI initiative. The...

Read more

ClearPoint Neuro Reports Third Quarter 2026 Results

October 28, 2026 4:05 PM

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced financial results for its third quarter ended September 30, 2026. Third Quarter 2026 Highlights Reported third quarter revenue of $12.1 million, representing 36% overall growth, including the recently acquired IRRAflow Portfolio; Neurosurgery navigation and therapy,...

Read more

OSR Health Provides Shareholder Update Following Nasdaq Panel Decision

October 28, 2026 9:15 AM

OSR Health, Inc. (OTC PINK:OSRH) ("OSR Health" or the "Company"), a global healthcare holding company, today provided an update to shareholders following the decision of the Nasdaq Hearings Panel to delist the Company's securities from The Nasdaq Stock Market. Nasdaq decision On October 23, 2026, the Nasdaq Hearings Panel determined to delist the Company's securities for non-compliance with Nasdaq's $1.00 minimum bid price requirement. The...

Read more

Microbix Reviews New U.S. Tariffs on Canada

October 28, 2026 7:00 AM

Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF)(Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is reviewing the effects of recent changes to United States ("U.S.") tariffs on Canada being imposed via Presidential proclamation using provisions of Section 338 of the Smoot-Hawley Tariff Act of 1930 (the "Act"). The Act was intended to protect U.S. industries during the Great Depression and enables the U.S....

Read more

Notice of Extraordinary General Meeting in Alligator Bioscience AB

October 27, 2026 1:35 PM

Alligator Bioscience (STO:ATORX) The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders of Alligator Bioscience AB, Reg. No. 556597-8201, are invited to the extraordinary general meeting to be held on Friday 27 November 2026 at 10:00 CET, at Medicon Village, conference room Bengt, Scheelevägen 4 in Lund, Sweden. RIGHT TO...

Read more

The Board of Directors of Alligator Bioscience Proposes a Reverse Share Split of Ordinary Shares

October 27, 2026 1:15 PM

Alligator Bioscience (STO:ATORX) - The Board of Directors of Alligator Bioscience AB ("Alligator Bioscience" or the "Company") proposes that an Extraordinary General Meeting on 27 November 2026 resolves to carry out a reverse share split of ordinary shares, in the ratio 1:1,000, resulting in one thousand (1,000) ordinary shares being consolidated into one (1) ordinary share (the "Reverse Share Split"). The Extraordinary General Meeting is also...

Read more

Invitation to Presentation of BioInvent's Interim Report January - September 2026

October 27, 2026 9:28 AM

BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) invites investors, analysts, and the press to a presentation of the interim report January-September 2026 on Thursday October 29 at 3:00 pm CET. The report will be published at 8:00 am CET the same day. BioInvent's CEO Martin Welschof will present the report together with CFO Stefan Ericsson. The presentation will be held in English. When: Thursday October 29, 2026, at 3:00 pm CET...

Read more

multiQure Sees Strong Interest in Partnering Talks Ahead of BIO-Europe 2026

October 27, 2026 9:00 AM

multiQure S.A. (WSE), a biotechnology company developing an RNAi gene therapy for Huntington's disease, will attend BIO-Europe 2026 in Cologne, Germany, on November 9-11, 2026. Two weeks ahead of the event, the Company has already scheduled 15 meetings with potential partners. The conference is the next step in building relationships with international biopharmaceutical companies that may be interested in multiQure's gene therapy and...

Read more

Pinnacle Food Group Limited Engages Strategic Advisor to Support M&A Initiatives

October 27, 2026 8:15 AM

Pinnacle Food Group Limited (NASDAQ:PFAI) ("Pinnacle Food" or the "Company"), a technology-driven company operating at the intersection of bioengineering and smart farming, today announced the engagement of Cupola Consulting LLC (the "Strategic Advisor") as strategic advisor to the Company in connection with its mergers and acquisitions ("M&A") initiatives, effective November 1, 2026. The engagement, which will be led by Noah Friedman, a Partner...

Read more

Synexis and Incubamaster Collaborate to Advance Continuous Indoor Pathogen Control Across Mexico's Poultry Industry

October 26, 2026 3:30 PM

Synexis®, LLC, the leader in touchless, continuous pathogen control technology, has announced a strategic collaboration with Incubamaster S.A. de C.V., one of Mexico's leading providers of commercial poultry, hatchery, and biosecurity technologies. The collaboration expands access to Synexis patented DHP® technology across Mexico, where together Synexis and Incubamaster are already helping poultry producers strengthen biosecurity, improve...

Read more

Bio Essence Corp Appoints Xiying (Thea) Zhang and Geoff Fellows as Independent Directors to Its Board

October 26, 2026 8:00 AM

Bio Essence Corp (OTCQB:BIOE) ("Bio Essence" or the "Company") today announced the appointment of Xiying (Thea) Zhang and Geoff Fellows to its Board of Directors as independent directors, effective October 19, 2026. The appointments expand the Board from three to five members, a majority of whom are now independent. Xiying (Thea) Zhang, CPIM, MBA, is Senior Supply Chain leader formerly with Oasis Pharmaceutical. She brings more than 15 years of...

Read more

Onyx BioLabs Peptides Reviews 2026 - Could This Be The Research Peptide Supplier You've Been Looking For?

October 26, 2026 7:20 AM

A published Certificate of Analysis (COA) gives a qualified laboratory buyer something concrete to examine before purchasing. It is still only a starting point. The questions that follow matter just as much. Does the report match the batch you are buying? What testing does it actually document? Can the issuing laboratory confirm it is real? This guide uses Onyx BioLabs' published materials as a worked example. It walks through five checks you...

Read more

RMTG's ISSCA Division Announces Successful Santa Cruz, Bolivia Conference, October 23-24

October 26, 2026 7:01 AM

Regenerative Medical Technology Group, Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, announces another successful ISSCA , its ISSCA division's regenerative medicine conference in Santa Cruz de la Sierra, Bolivia, this last weekend October 23-24 at Hotel Los Tajibos. The Santa Cruz conference extends ISSCA's Latin American physician-education...

Read more

Microbix Presenting at Planet MicroCap Investment Conference

October 26, 2026 7:00 AM

Microbix Biosystems Inc. (TSX:MBX, OTCQX:MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Planet MicroCap Toronto 2026 Investment Conference, powered by MicroCapClub and being hosted at the Arcadian Loft, 8th Floor, 401 Bay Street, Toronto, Ontario on October 27-29, 2026. During the conference, Microbix's CEO, Cameron Groome, will present and have one-on-one...

Read more

Path Fertility Awarded $2 Million NIH Grant to Develop Epigenetic Test for Severe Male Infertility and Associated Cancer Risk

October 26, 2026 6:08 AM

Path Fertility™, the commercial brand of Inherent Biosciences, Inc. and a molecular diagnostics company advancing epigenetic testing for male fertility, today announced it has received a Direct to Phase II Small Business Innovation Research (SBIR) grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH). The two-year award, totaling $2 million, will...

Read more